Radiation therapy as a backbone of treatment of locally advanced non-small cell lung cancer

Aaron M. Laine, Kenneth D. Westover, Hak Choy

Research output: Contribution to journalArticlepeer-review

16 Scopus citations


Locally advanced non-small cell lung cancer (LA-NSCLC) is a heterogeneous disease, encompassing stage IIIA, for which surgery in combination with chemotherapy and/or radiation therapy (RT) represents a potential treatment approach for select patients, and stage IIIB, for which chemoradiation represents the standard of care. Recent advances in systemic cytotoxic and molecularly targeted therapies coupled with technologic innovations in radiotherapy have the potential to improve outcomes for this patient population. Many ongoing clinical trials use specific genetic mutations or histologic status to determine the combination of targeted therapies and RT, as well as to determine the optimal chemoradiotherapy platforms. Additionally, use of modern RT techniques has improved outcomes for some patients with limited metastatic disease, thereby prompting further studies on how to best integrate aggressive management of oligometastases using RT with chemotherapeutic regimens.

Original languageEnglish (US)
Pages (from-to)57-68
Number of pages12
JournalSeminars in oncology
Issue number1
StatePublished - Feb 2014

ASJC Scopus subject areas

  • Hematology
  • Oncology


Dive into the research topics of 'Radiation therapy as a backbone of treatment of locally advanced non-small cell lung cancer'. Together they form a unique fingerprint.

Cite this